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Main Data
 Paper based method for rapid detection of 
Tuberculosis. 
 The microfluidic device contains a stack of 
three papers separated by a paper the stack 
of these paper are coated with 
 Barbituric acid:- is an organic 
compound based on a pyrimidine 
hetrocyclic skeleton. It is an odorless 
powder soluble in water.
 Chloramine T:-Chloramine-T is slightly 
basic (pH typically 8.5). In water, it breaks 
down to the disinfectant hudrochlorite. 
Chloramine-T is available in tablet or 
powder form and has to be dissolved before 
Introduction
Many developing countries do not have access
to the best medical diagnostic technologies.
These medical devices are designed for air-
conditioned laboratories, refrigerated storage of
chemicals, a constant supply of calibrators and
reagents, stable electrical power, highly trained
personnel and rapid transportation of samples.
Micro-fluidic systems designed today allow
miniaturization and integration of complex
functions, which could move sophisticated
diagnostic tools out of the developed-world
laboratory. These systems must be
inexpensive, but also accurate, reliable, rugged
and well suited to the medical and social
contexts of the developing world.
Purpose
Micro-fluidic systems can be designed to 
obtain and process measurements from small 
volumes of complex fluids with efficiency and 
speed. set of capabilities is precisely what is 
needed to create portable point-of-care (POC) 
medical diagnostic systems.1,2 The world’s 
population of 6.1 billion people, 3 billion lack 
Experiments
Step 1 Preparation of the sample in with 10% 
concentration. The stack of the papers are coated 
three sample and kept to dry.
Step 2. Stack of paper coated with Barbituric acid 
(B), Chloramine T hydrate( C ) and potassium 
thycyanate(K) is separated by micron paper. The 
top stack is then coated with 2% PVA
Step 3.The acrylic sheet of paper is then placed on 
the stack and packed using an scotch tape keeping 
the top hole empty. This fabricated device is then 
ready for testing. 
Step 4 The and isonicotinic acid (1%) is passed 
through the hole in the fabricated device. 
Isonicotonic acid share the same structure as 
Tuberculosis metabolites. So when they enter the 
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use. It is sprayed on a surface and allowed 
to stand for at least 15 minutes before 
being wiped off or allowed to dry
 Potassium thiocyanate:- It is the chemical 
compound with the molecular formula 
KSCN.
 isonicotinic acid:- Isonicotinic acid is an 
organic compound with a carboxyl group on 
a pyridine ring. It is an isomer of nocotonic 
acid — the carboxyl group for isonicotinic 
acid is on the 4-position instead of the 3-
position for nicotinic acid.
 Inkjet Printed acrylic sheet:- A acrylic sheet 
is printed with a cube structure of 1”x1”. A 
hole is then punched in these cubes of 0.5 
cm.
 Polyvenyl Alcohol :- Poly-vinyl alcohol 
(PVA) is a low temperature thermoplastic 
with the interesting property of being 
soluble in water. With a melting point below 
that of PLA and a texture and compression 
profile similar to ABS it is relatively easy to 
extrude. However, because of PVA's 
sensitivity to water, even mild humidity can 
ruin an unsealed spool of filament.
basic sanitation, 2 billion do not have access 
to electricity and more than 1 billion lack basic 
healthcare services and clean drinking 
water5,6.
fabricated device they try pink and then reliving a 
blue color indicating presence of TB.
Step 5The result observed with stack of [BCK] 
where one K+ is coated with PVA and the results 
are as follows.
Step 6 When the stack is inverted [K C B ] where 
B+ is coated with  PVA and the results shows that 
paper turn blue faster than [B C K]
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improved POC methods are needed to
return same-day test results so that patients
can receive appropriate therapy while they
are still at the clinic.
Point-of-care (POC) diagnostics offer great
potential to detect and monitor infectious
diseases
at resource-limited settings, because POC
diagnostics can be taken to remote locations,
decreasing the need for large decentralized
diagnostics facilities. Desired characteristics
of
POC diagnostic technologies include (i) 
disposability, (ii) cost-effectiveness, (iii) ease 
of use and (iv) portability [8]. POC diagnostics 
should be able to analyze small volumes of 
bodily fluids, e.g., blood, saliva and urine. 
Global health programs are significantly 
hindered because such tests are currently 
unavailable. There is also need for individual 
tests for emerging and re-emerging diseases 
such as tuberculosis,
